The four heart-failure drug classes, titrated toward target dose.
Clinical · Full PHI · CardiologyIn development — not installable yet. Join the waitlist and we will tell you when it opens.
A heart failure patient’s four guideline-directed drug classes are tracked against their target doses, and the app flags whoever in the clinic’s panel is still on a starting dose months after diagnosis — the under-treatment that guideline audits consistently find but that a single-visit view never shows.
It does not titrate the dose — the cardiologist does; the app tracks progress toward target and flags who has stalled.
Every app page carries this section. A listing with only benefits is an advertisement.GDMTTrack reads medication list, heart failure diagnosis and writes titration status, under-treatment flags. Its data class is Full PHI. Every app works on the same patient record — nothing is copied into a silo.
It does not titrate the dose — the cardiologist does; the app tracks progress toward target and flags who has stalled.
Nothing to remove yet — this app is in development.
Not yet — GDMTTrack is in development and cannot be installed. Join the waitlist and we will tell you when it opens.
GDMTTrack is in development and cannot be installed yet. Leave your name and number: the waitlist decides what we build next, and we will tell you when it opens.